Opinion on Transition Therapeutics Inc. (TTHI)
Upcoming Clinical Trials data of a small cap company's Alzheimer's drug to be presented in July

Jun 26, 2009 10:37 AM GMT

tanumoy

Return	Risk
-30.77%	LOW

Analyst

Profile & Performance

Subscribe to author

TTHI is going to be presenting data on their Alzheimer's disease drug (ELND-005) at the Alzheimer's conference in July. If the trials data is positive, it brings the company one step closer to the approval of thier breakthrough treatment for Alzheimer's disease. To find out about the drug, how the drug works, who are the other players developing drugs in this area and how TTHI's drug compares with the rest, read a FREE report of the upcoming trials data at: http://www.newbiomedicine.com

TTHI: This call was made on 06/26/09 @ $3.64

Rating:	$3.64 (06/26/09)
Gain/Loss:	-30.49% in 229 days
Target:	$5.00 (+37.36%) in < two weeks

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+35.78%	410
2	Gerald Greene	18.14	+54.81%	232
3	stockmarketfunding.com	17.66	+24.06%	62
4	akiralegrand	13.47	+14.32%	65
5	anup2104	12.13	+70.53%	52

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
INTC	Intel Corp
T	AT&T Inc
JPM	JPMorgan Chase & Co
RIMM	Research in Motion Ltd
MO	Altria Group Inc
BAC	Bank of America Corp

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

KO		KO Short by Mikey
VQ		Venoco, Inc. (VQ) - Insiders are selling by stockexpert
XNPT		Xenoport - A Shaking Ham Hock by Wax Ink
FITB		Too-big-to-fail TARP banks need to meet their maker by utopius
HPQ		Mark Hurd is awesome, but... by utopius

... more »

Transition Therapeutics Inc. (TTHI)

SocialPicks Sentiment: N/A

This Quarter's Sentiment:

All:

87.5%

Top:

100.0%

Get Daily Email Alerts

Subscribe to tanumoy

Receive Free Ideas Daily for This Sector

Latest Picks by tanumoy

Symbol	SP Sentiment	Rating	Return	Since

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on Transition Therapeutics Inc. (TTHI) Upcoming Clinical Trials data of a small cap company's Alzheimer's drug to be presented in July

Opinion on Transition Therapeutics Inc. (TTHI)
Upcoming Clinical Trials data of a small cap company's Alzheimer's drug to be presented in July